BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10416733)

  • 1. Should schizophrenia be treated as a neurocognitive disorder?
    Green MF; Nuechterlein KH
    Schizophr Bull; 1999; 25(2):309-19. PubMed ID: 10416733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying the effectiveness of neurocognitive remediation in schizophrenia.
    Jaeger J
    Schizophr Bull; 1999; 25(2):193-6. PubMed ID: 10416725
    [No Abstract]   [Full Text] [Related]  

  • 3. Interventions for neurocognitive deficits: editor's introduction.
    Green MF
    Schizophr Bull; 1999; 25(2):197-200. PubMed ID: 10416726
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of neurocognitive remediation on executive processing in patients with schizophrenia.
    Wykes T; Reeder C; Corner J; Williams C; Everitt B
    Schizophr Bull; 1999; 25(2):291-307. PubMed ID: 10416732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits and cognitive training in schizophrenic patients: a review.
    Rund BR; Borg NE
    Acta Psychiatr Scand; 1999 Aug; 100(2):85-95. PubMed ID: 10480194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cognitive dysfunction in psychiatric disorders.
    Medalia A; Lim R
    J Psychiatr Pract; 2004 Jan; 10(1):17-25. PubMed ID: 15334984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Learning potential and cognitive remediation in schizophrenia].
    Raffard S; Gely-Nargeot MC; Capdevielle D; Bayard S; Boulenger JP
    Encephale; 2009 Sep; 35(4):353-60. PubMed ID: 19748372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
    Keefe RS; Silva SG; Perkins DO; Lieberman JA
    Schizophr Bull; 1999; 25(2):201-22. PubMed ID: 10416727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do cognitive sciences open therapeutic paths in schizophrenia?].
    Saoud M; Senn M; Daléry J
    Encephale; 2006 Oct; 32(5 Pt 4):S903-6; discussion S907. PubMed ID: 17119501
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive rehabilitation for schizophrenia: problems, prospects, and strategies.
    Bellack AS; Gold JM; Buchanan RW
    Schizophr Bull; 1999; 25(2):257-74. PubMed ID: 10416730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?
    Green MF; Kern RS; Braff DL; Mintz J
    Schizophr Bull; 2000; 26(1):119-36. PubMed ID: 10755673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted cognitive remediation in schizophrenia: what is the active ingredient?
    Kurtz MM; Seltzer JC; Shagan DS; Thime WR; Wexler BE
    Schizophr Res; 2007 Jan; 89(1-3):251-60. PubMed ID: 17070671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
    Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
    Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive remediation program for individuals living with schizophrenia (Recos): preliminary results].
    Deppen P; Sarrasin Bruchez P; Dukes R; Pellanda V; Vianin P
    Encephale; 2011 Sep; 37(4):314-21. PubMed ID: 21981893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurocognitive disorders in psychiatry: a case example of diagnostic and treatment dilemmas.
    Weinstein CS; Seidman LJ; Feldman JJ; Ratey JJ
    Psychiatry; 1991 Feb; 54(1):65-75; discussion 76-7. PubMed ID: 2023975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia.
    Wykes T; Reeder C; Williams C; Corner J; Rice C; Everitt B
    Schizophr Res; 2003 Jun; 61(2-3):163-74. PubMed ID: 12729868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and impact of metacognitive deficits in schizophrenia].
    Quiles C; Prouteau A; Verdoux H
    Encephale; 2013 Apr; 39(2):123-9. PubMed ID: 23219408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal cognitive therapy: combining treatments that bypass cognitive deficits and deal with reasoning and appraisal biases.
    Velligan DI; Draper M; Stutes D; Maples N; Mintz J; Tai S; Turkington D
    Schizophr Bull; 2009 Sep; 35(5):884-93. PubMed ID: 19620602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What perspectives for cognitive remediation in schizophrenia?].
    Correard N; Mazzola-Pomietto P; Elissalde SN; Viglianese-Salmon N; Fakra E; Azorin JM
    Encephale; 2011 Dec; 37 Suppl 2():S155-60. PubMed ID: 22212847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.